It was made public in an electronic document that’s filled with the Washington-based SEC that Andrew Gordon, who works for Coffee Holding Co Inc, and serves as President and CEO finalized an insider deal on April 07, 2017. Andrew obtained 1,700 shares of the company calculated based on $4.6 U.S. Dollars for each share. As reported in the legal document available for free here, the total amount of the deal was $7,788 U.S. Dollars. He also bought 5,000 shares with value $23,312 USD in the last month. Andrew Gordon now has in hand 256,450 shares of the Firm.
Rigel Pharmaceuticals, Inc. is a clinical-stage biotechnology company. The company has market cap of $370.55 million. The Firm is engaged in the discovery and development of targeted drugs in the therapeutic areas of immunology, oncology and immuno-oncology. It currently has negative earnings. The Company’s clinical programs include clinical studies of fostamatinib, an oral spleen tyrosine kinase inhibitor in a range of indications.
Sio Capital Management Llc holds 1.75% of its portfolio in Rigel Pharmaceuticals, Inc. for 1.26 million shares. Cormorant Asset Management Llc owns 2.87 million shares or 0.92% of their US portfolio. Moreover, Rhenman & Partners Asset Management Ab has 0.58% invested in the company for 1.28 million shares. The California-based Palo Alto Investors Llc has invested 0.57% in the stock. Ghost Tree Capital Llc, a New York-based fund reported 700,000 shares.
The stock increased 1.64% or $0.05 during the last trading session, reaching $3.09. About 1.08 million shares traded. Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) has declined 9.79% since August 31, 2016 and is downtrending. It has underperformed by 18.38% the S&P500.
Analysts await Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) to report earnings on May, 2. They expect $-0.12 earnings per share, up 36.84% or $0.07 from last year’s $-0.19 per share. After $-0.16 actual earnings per share reported by Rigel Pharmaceuticals, Inc. for the previous quarter, Wall Street now forecasts -25.00% EPS growth.
Ratings analysis reveals 100% of Rigel Pharmaceuticals’s analysts are positive. Out of 4 Wall Street analysts rating Rigel Pharmaceuticals, 4 give it “Buy”, 0 “Sell” rating, while 0 recommend “Hold”. The lowest target is $3.25 while the high is $11. The stock’s average target of $7.05 is 128.16% above today’s ($3.09) share price. RIGL was included in 7 notes of analysts from August 8, 2015. The stock of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) earned “Buy” rating by Jefferies on Monday, May 16. The company was initiated on Monday, June 13 by Piper Jaffray. The firm earned “Buy” rating on Wednesday, July 13 by H.C. Wainwright. The stock has “Hold” rating by Zacks on Saturday, August 8. The firm earned “Buy” rating on Wednesday, August 31 by H.C. Wainwright. As per Wednesday, August 31, the company rating was maintained by BMO Capital Markets. The rating was maintained by Piper Jaffray on Tuesday, August 30 with “Overweight”.
Since January 1, 0001, it had 0 buys, and 1 sale for $12,028 activity.
Coffee Holding Co., Inc. is a wholesale coffee roaster and dealer in the United States. The company has market cap of $26.94 million. The Firm is engaged in manufacturing, roasting, packaging, marketing and distributing roasted and blended coffees for private labeled accounts and its own brands, and it sells green coffee. It has a 12.91 P/E ratio. The Company’s products can be divided into three categories: Wholesale Green Coffee, Private Label Coffee and Branded Coffee.
Investors sentiment decreased to 1 in 2016 Q4. Its down 0.50, from 1.5 in 2016Q3. It dived, as 4 investors sold Coffee Holding Co., Inc. shares while 5 reduced holdings. 3 funds opened positions while 6 raised stakes. 961,281 shares or 0.29% more from 958,545 shares in 2016Q3 were reported. Neuberger Berman Ltd reported 137,575 shares. Raymond James And Associate holds 52,800 shares. Moreover, Walleye Trading Lc has 0% invested in Coffee Holding Co., Inc. (NASDAQ:JVA) for 1,200 shares. Kcg Hldgs Inc holds 22,250 shares or 0% of its portfolio. Ancora Advsrs Limited Liability has invested 0.07% of its portfolio in Coffee Holding Co., Inc. (NASDAQ:JVA). Moreover, Blackrock Fund Advisors has 0% invested in Coffee Holding Co., Inc. (NASDAQ:JVA). Morgan Stanley invested in 0% or 5,293 shares. Dimensional Fund Lp holds 42,135 shares. James reported 0% in Coffee Holding Co., Inc. (NASDAQ:JVA). 12,200 are held by California Pub Employees Retirement. Financial Bank Of America Corp De reported 2 shares. Grt Cap Partners Lc invested in 0.03% or 23,161 shares. Geode Cap Management Limited Liability Com has 22,341 shares for 0% of their portfolio. Vanguard Grp Inc has 192,868 shares. Invest Group Incorporated Ltd accumulated 11,675 shares.
The stock decreased 0.22% or $0.01 on April 7, reaching $4.59. About 9,904 shares traded. Coffee Holding Co., Inc. (NASDAQ:JVA) has declined 19.72% since August 31, 2016 and is downtrending. It has underperformed by 28.31% the S&P500.
